Newsroom

TOKYO--(BUSINESS WIRE)--NTT DOCOMO GLOBAL and Accenture are teaming up to develop and scale the Universal Wallet Infrastructure (UWI)....

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: NATIXIS SA (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.   (c) Name o...

SAN FRANCISCO--(BUSINESS WIRE)--Encellin, a biotechnology company pioneering Encapsulated Cell Replacement Therapy (ENCRT), today announced interim clinical results from its ongoing Phase 1 investigational trial (NCT06408311) in study subjects with Type 1 Diabetes. Analyses of explants from the initial five subjects at prespecified timepoints demonstrated non-fibrotic engraftment with robust vascularization around the ENCRT implant after a 4-month implantation. Importantly, in the initial evalu...

PLANO, Texas--(BUSINESS WIRE)--Digital Matrix Systems announced the addition of ten new tri-bureau attributes to its DMS Summary Attributes® library....

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Moderate Buffer UCITS ETF - November 05.01.2026 GNOV LN IE000OJ31JQ4 950,002.00 USD 33,369,288.56 35.125  ...

TORONTO--(BUSINESS WIRE)--Bragg Gaming Group (NASDAQ: BRAG, TSX: BRAG) (“Bragg” or the “Company”), a leading content-driven iGaming technology provider, today announced a strategic partnership with Golden Whale Productions ("Golden Whale"), a recognized leader in iGaming data science. This collaboration directly supports the Company’s current strategic objectives of utilizing artificial intelligence (“AI”) to drive cost efficiencies and improve operational excellence and marks a major milestone...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--3T Biosciences, an immunotherapy company changing the future of treatment for solid tumors and other immune-mediated diseases, today announced the appointments of Behzad Kharabi, M.D., as chief medical officer, and Karen E. Knudsen, MBA, Ph.D., chief executive officer (CEO) of the Parker Institute for Cancer Immunotherapy (PICI), to its board of directors. The appointments bring extensive clinical development, translational oncology, and strategic l...

MIAMI--(BUSINESS WIRE)--DemeRx, Inc., a clinical-stage biopharmaceutical company dedicated to transforming addiction therapeutics, today announced positive results from its Phase 1 multiple ascending dose (MAD) study of DMX-1001 (oral noribogaine) for the treatment of alcohol use disorder (AUD). The results demonstrated safety, tolerability, and pharmacokinetics that support advancing DMX-1001 to Phase 2 clinical trials in people with AUD. The Phase 1 clinical trial was a double-blind, placebo-...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Moderate Buffer UCITS ETF- August 05.01.2026 GAUG LN IE000TGSG3Y5 650,002.00 USD 22,985,413.15 35.362  ...

WALTHAM, Mass.--(BUSINESS WIRE)--BostonGene, the developer of the leading AI foundation model for tumor and immune biology, today announced a strategic collaboration with AstraZeneca, a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialization of prescription medicines in Oncology, Rare Diseases and BioPharmaceuticals, to advance oncology drug development using BostonGene’s multimodal AI platform. The collaboration leverages BostonGene’s foun...